June 25, 2024
Acute myeloid leukemia (AML) is a cancer of the bone marrow and the blood that progresses rapidly without treatment. The National Cancer Institute estimates 20,800 new cases of AML will be diagnosed in 2024, which would represent 1% of new cancer cases in the United States. It is most often diagnosed in people between the ages of 65 and 74, with a median age of 69. Although uncommon, AML can occur in children. The five-year relative survival rate is 31.9%. Now, researchers at Purdue University’s College of Science and collaborators have developed a patent-pending compound called HSN748 to treat drug-resistant AML.
Overcoming Drug-Resistant Acute Myeloid Leukemia with Engineered Compound
June 24, 2024
Purdue University researchers have unveiled biosensor technology aimed at transforming agricultural practices by swiftly identifying contamination risks in fresh produce.
Purdue researchers introduce biosensor technology for agriculture
June 24, 2024
Purdue University researchers in the College of Science have developed a patent-pending technology called RPOC, or real-time precision opto-control, which allows users to have site-specific and chemical-specific control of chemical processes within live cells.
Purdue technology provides site- and chemical-specific control of processes within live cells
June 24, 2024
Research to understand and quantify the effectiveness of a specific combination therapy against breast cancer has been singled out to receive the Purdue Women’s Global Health Institute’s 2024 Catherine Peachey Breast Cancer Research Program Award.
Promising breast cancer research receives WGHI’s Catherine Peachey grant
June 21, 2024
The number of women in STEM fields, including engineering, has increased in recent decades, paving the way for a brighter, more representative future in the U.S. International Women in Engineering Day spotlights these trailblazing women and their achievements in various engineering disciplines. Founded by the Women’s Engineering Society in the U.K., the day is now recognized across the world on June 23. The day has the broader aim of inspiring future generations of women engineers, fostering diversity and inclusivity in the field.
International Women in Engineering Day: Q&A with Kari Clase and Upinder Kaur
June 21, 2024
The American College of Veterinary Internal Medicine (ACVIM) recently announced recipients of the esteemed 2024 ACVIM Recognition Awards, and one of them is Dr. François-René Bertin, Purdue associate professor of large animal internal medicine. Dr. Bertin, who joined the Purdue Veterinary Medicine faculty in January of this year, received the William R. Fenner Early Career Award for Outstanding Service. The award recognizes ACVIM Diplomates who exemplify exceptional service in a volunteer capacity in the ACVIM and/or their specialty within the first 10 years following board-certification.
Purdue Associate Professor of Large Animal Internal Medicine Receives Prestigious ACVIM Award
June 20, 2024
Researchers at Purdue University’s College of Science have developed a patent-pending compound called HSN748 to treat drug-resistant acute myeloid leukemia (AML). AML is a cancer that begins in bone marrow and sometimes metastasizes to the central nervous system, liver, lymph nodes, spleen and testicles.
‘Like a hand fitting into a glove’: Purdue-engineered compound designed to treat drug-resistant acute myeloid leukemia
June 20, 2024
Indiana University School of Medicine researchers and their collaborators have uncovered molecular insights expected to enhance treatment options for acute myeloid leukemia (AML), a rare and severe blood and bone marrow cancer. With a new chemical compound engineered to overcome drug-resistant gene mutations not targeted by current treatments, the researchers aim to provide a new alternative with longer-lasting effects and improve outcomes for future patients battling this aggressive disease.
Acute myeloid leukemia discovery tackles drug-resistant gene mutations
June 20, 2024
Researchers at Purdue University’s College of Science have developed a patent-pending compound called HSN748 to treat drug-resistant acute myeloid leukemia (AML). AML is a cancer that begins in bone marrow and sometimes metastasizes to the central nervous system, liver, lymph nodes, spleen and testicles.
‘Like a hand fitting into a glove’: Purdue-engineered compound designed to treat drug-resistant ...
June 20, 2024
Purdue University researchers are introducing a new biosensor technology to the agricultural industry inspired by advancements achieved during the COVID-19 pandemic.
Paper-based biosensor offers fast, easy detection of fecal contamination on produce farms
